内血管动脉瘤封堵联合烟囱移植物后的移植物迁移
回顾性观察队列研究纳入31例肾旁腹主动脉瘤患者,接受内血管动脉瘤封堵联合烟囱移植物(chEVAS)治疗,基于25例分析移植物迁移。术后2年内无>10 mm尾侧迁移,但近四分之一患者出现5–9 mm尾侧移动;3年时2例出现需再干预的迁移及Ia型内漏。chEVAS技术挑战大,仅建议无其他可行治疗选择的患者使用。
要点
- chEVAS术后2年内无>10 mm尾侧迁移,但5–9 mm尾侧移动1年免于率86.1%、2年73.9%。
- 3年随访出现2例5–9 mm尾侧移动及Ia型内漏需再干预,临床相关迁移免于率1年和2年均为100%。
- 迁移与动脉瘤增长、内漏或烟囱移植物数量无相关性(p值分别为0.851、0.562、0.728)。
核心结论
- chEVAS术后2年内无>10 mm尾侧迁移,但近四分之一患者出现5–9 mm尾侧移动,3年随访观察到需干预的持续迁移趋势。
- chEVAS技术挑战大,应仅考虑用于无可行替代治疗的患者。
研究设计与样本
- 多数患者接受>1个烟囱移植物(13例单烟囱、13例双烟囱、5例三烟囱);6例仅有术后首次扫描,迁移分析基于25例患者。
主要发现
- 首次术后CT评估中位封堵长度为36.5 mm;辅助技术成功率为93.5%,2例技术失败。
- 25例患者中位最终影像随访时间为17个月;末次随访无尾侧迁移>10 mm病例。
- 5–9 mm尾侧移动免于率1年为86.1%、2年为73.9%;临床相关迁移(需再干预的移动)免于率1年和2年均为100%。
- 3年时出现2例5–9 mm尾侧移动及Ia型内漏需再干预;迁移与动脉瘤增长(p=0.851)、内漏(p=0.562)或烟囱移植物数量(p=0.728)无相关性。
- 随访期间2例(7%)动脉瘤破裂,10例(33%)再干预,8例(27%)死亡,其中2例(7%)动脉瘤相关且死于再干预后果。
临床怎么用
- chEVAS后需密切影像随访监测尾侧迁移和Ia型内漏,尤其2年后仍可能出现需再干预的迁移。
- 因技术挑战大且远期迁移风险,chEVAS应仅用于无其他可行治疗选择的肾旁腹主动脉瘤患者。
局限性
- 回顾性观察设计,样本量小(31例,迁移分析仅25例),随访时间有限(中位17个月)。
- 6例患者缺乏术后首次扫描外的影像,未纳入迁移分析,可能影响结果代表性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess the incidence of migration after endovascular aneurysm sealing (EVAS) in conjunction with chimney grafts (chEVAS) for repair of abdominal aortic aneurysms (AAAs). MATERIALS AND METHODS: A retrospective, observational cohort study was conducted of 31 patients (mean age 75.7 years; 27 men) treated for juxtarenal AAA between April 2013 and December 2018 at single centers in New Zealand and the Netherlands. The majority of patients received >1 chimney graft (13 single, 13 double, and 5 triple) during chEVAS. Six patients had only the first postoperative scan, so the migration analysis was based on 25 patients. RESULTS: Median seal length assessed on the first postoperative computed tomography scan was 36.5 mm. The assisted technical success rate was 93.5% with 2 technical failures. Median time to final imaging follow-up was 17 months in 25 patients. At the latest follow-up, there were no cases of caudal migration >10 mm. Freedom from caudal movement of 5 to 9 mm was estimated as 86.1% at 1 year and 73.9% at 2 years; freedom from clinically relevant migration (movement requiring reintervention) was 100% at both time intervals. However, at 3 years there were 2 cases of caudal movement of 5 to 9 mm and a type Ia endoleak warranting reintervention. No correlation between migration and aneurysm growth (p=0.851), endoleak (p=0.562), or the number of chimney grafts (p=0.728) was found. During follow-up, 2 patients (7%) had aneurysm rupture and 10 (33%) had reinterventions. Eight patients (27%) died; 2 were aneurysm-related (7%) and due to the consequences of a reintervention. CONCLUSION: In the 2 years following chEVAS, there was no caudal migration >10 mm, but nearly a quarter of patients had caudal movement of 5 to 9 mm. A trend was observed toward ongoing migration that required intervention at 3-year follow-up. chEVAS is technically challenging and should be considered only for patients with no viable alternative treatment option.
引用
- Zoethout AC, Sheriff A, Zeebregts CJ, et al. Migration After Endovasclar Aneurysm Sealing in Conjunction With Chimney Grafts. J Endovasc Ther. 2020. PMID: 32909531. doi:10.1177/1526602820957279
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。